© 2002 Thorax
ORIGINAL ARTICLE
Expression of p21 in SV40 large T antigen positive human pleural mesothelioma: relationship with survival
1 Laboratory C, Department for the Development of Therapeutical Programs, Center for Experimental Research, Regina Elena Cancer Institute, Rome, Italy
2 Department of Biochemistry and Biophysic "F Cedrangolo", Section of Pathology, Second University of Naples, Italy
3 Department of Cardiothoracic Surgery, University of Vienna, Austria
4 U.O. of Respiratory Diseases, Civil Hospital of Caserta, Italy
5 Campus BioMedico University, Rome, Italy
6 Institute of Thoracic Surgery, Second University of Naples, Italy
Correspondence to:
Correspondence to:
Dr A Baldi, Laboratory C, Department for the Development of Therapeutical Programs, Center for Experimental Research, Regina Elena Cancer Institute, Via delle Messi d'Oro 156, 00158 Rome, Italy;
baldi{at}ifo.it
Background: Mesothelioma is the most commonly occurring primary pleural neoplasm. Several studies have documented an increase in the incidence of this malignancy during the last decades. Although the association between asbestos exposure and development of mesothelioma is generally accepted, the exact mechanism of carcinogenesis is unknown. Recently, Simian virus 40 large T antigen (SV40 Tag) expression has been detected in pleural mesothelioma. The ability of SV40 oncoproteins to inactivate p53 and retinoblastoma tumour suppressor proteins has been proposed as an important step in the pathogenesis of human mesothelioma.
Methods: To obtain a better understanding of the molecular mechanisms of the pathogenesis of mesothelioma, the expression of the cell cycle inhibitor p21WAF1/CIP1 (p21), a downstream target of p53, was evaluated immunohistochemically in a group of 29 mesothelioma specimens already characterised for the presence of SV40 Tag sequences.
Results: Statistical analysis did not reveal any correlation between p21 expression and histopathological type of mesothelioma using the
2 test (p=0.577). A significant positive relationship was found between p21 expression level and the patients' overall survival according to the Kaplan-Meier survival curves and using a log rank test (median difference in survival 7 months, 95% CI 4.8 to 9.9; p<0.001).
Conclusions: Determination of p21 expression bears a prognostic significance in patients affected with mesothelioma, further underlining the role of SV40 in the pathogenesis of malignant pleural mesothelioma.
Keywords: mesothelioma; p21WAF1; CIP1; immunohistochemistry; SV40 large T antigen
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Spugnini, E. P., Cardillo, I., Verdina, A., Crispi, S., Saviozzi, S., Calogero, R., Nebbioso, A., Altucci, L., Cortese, G., Galati, R., Chien, J., Shridhar, V., Vincenzi, B., Citro, G., Cognetti, F., Sacchi, A., Baldi, A.
(2006). Piroxicam and Cisplatin in a mouse model of peritoneal mesothelioma.. Clin. Cancer Res.
12: 6133-6143
[Abstract] [Full Text] -
Baldi, A, Santini, D, Vasaturo, F, Santini, M, Vicidomini, G, Di Marino, M P., Esposito, V, Groeger, A M, Liuzzi, G, Vincenzi, B, Tonini, G, Piccoli, M, Baldi, F, Scarpa, S
(2004). Prognostic significance of cyclooxygenase-2 (COX-2) and expression of cell cycle inhibitors p21 and p27 in human pleural malignant mesothelioma. Thorax
59: 428-433
[Abstract] [Full Text] -
Upadhyay, D., Kamp, D. W.
(2003). Asbestos-Induced Pulmonary Toxicity: Role of DNA Damage and Apoptosis. Exp. Biol. Med.
228: 650-659
[Abstract] [Full Text]
eLetters:
Read all eLetters
- Other non asbestos causes of mesothelioma besides the SV40 virus
- John H. Lange
- Thorax Online, 1 Mar 2004 [Full text]
- Analysis of mesothelioma pathogenesis
- Alfonso Baldi, et al.
- Thorax Online, 5 Mar 2004 [Full text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
